CQS Cayman LP acquired a new stake in shares of Xylem Inc (NYSE:XYL) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 88,747 shares of the industrial products company’s stock, valued at approximately $7,423,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in XYL. BlackRock Inc. grew its position in Xylem by 3.6% during the first quarter. BlackRock Inc. now owns 14,986,762 shares of the industrial products company’s stock valued at $1,184,554,000 after buying an additional 516,715 shares during the period. Parnassus Investments CA grew its position in Xylem by 2.1% during the second quarter. Parnassus Investments CA now owns 6,407,410 shares of the industrial products company’s stock valued at $535,916,000 after buying an additional 133,286 shares during the period. Geode Capital Management LLC grew its position in Xylem by 6.3% during the fourth quarter. Geode Capital Management LLC now owns 2,270,489 shares of the industrial products company’s stock valued at $151,217,000 after buying an additional 134,307 shares during the period. Northern Trust Corp grew its position in Xylem by 0.5% during the first quarter. Northern Trust Corp now owns 2,235,775 shares of the industrial products company’s stock valued at $176,716,000 after buying an additional 10,680 shares during the period. Finally, Amundi Pioneer Asset Management Inc. grew its position in Xylem by 5.5% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 1,754,058 shares of the industrial products company’s stock valued at $138,641,000 after buying an additional 91,397 shares during the period. 84.58% of the stock is owned by hedge funds and other institutional investors.
Shares of XYL traded up $0.60 during mid-day trading on Friday, reaching $78.67. The stock had a trading volume of 726,217 shares, compared to its average volume of 606,128. The firm has a market cap of $14.27 billion, a price-to-earnings ratio of 27.32, a PEG ratio of 1.52 and a beta of 1.20. Xylem Inc has a 12 month low of $60.65 and a 12 month high of $85.39. The business has a fifty day moving average of $77.14 and a 200 day moving average of $78.82. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.08 and a current ratio of 1.47.
Xylem (NYSE:XYL) last posted its quarterly earnings results on Thursday, August 1st. The industrial products company reported $0.79 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.79. The business had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.35 billion. Xylem had a net margin of 10.90% and a return on equity of 19.23%. The company’s revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.73 earnings per share. On average, research analysts forecast that Xylem Inc will post 3.17 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th will be given a $0.24 dividend. The ex-dividend date is Wednesday, August 28th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 1.22%. Xylem’s payout ratio is currently 33.33%.
In other Xylem news, SVP Kenneth Napolitano sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $77.49, for a total value of $387,450.00. Following the completion of the transaction, the senior vice president now directly owns 46,228 shares in the company, valued at $3,582,207.72. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Tomas Brannemo sold 6,683 shares of the company’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $81.90, for a total transaction of $547,337.70. Following the completion of the transaction, the insider now owns 20,161 shares of the company’s stock, valued at $1,651,185.90. The disclosure for this sale can be found here. Over the last quarter, insiders sold 28,027 shares of company stock valued at $2,252,433. Company insiders own 0.85% of the company’s stock.
Several analysts recently issued reports on the stock. ValuEngine lowered shares of Xylem from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Credit Suisse Group lowered shares of Xylem from an “outperform” rating to a “neutral” rating in a research report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have assigned a buy rating to the stock. Xylem presently has an average rating of “Hold” and a consensus target price of $78.83.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
Featured Story: How are institutional investors different from individual investors?
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.